Clinical Trial Update: Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Genotonorm for growth rate in children with growth retardation due to glucocorticosteroid therapy; study completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Genotonorm (somatropin)

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2015-06-25